[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2014-2018 US Hematology and Flow Cytometry Markets: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies

November 2014 | 275 pages | ID: N3D8E71884DEN
Venture Planning Group

US$ 7,880.00 US$ 9,850.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Complete report $9,850.DataPack (test volumes, sales forecasts, supplier shares) $6,400.

New Frontiers in US Hematology and Flow Cytometry Markets: Business Challenges, Emerging Technologies, Competitive Landscape is VPGMarketResearch.com new study designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the U.S. hematology and flow cytometry markets during the next five years.

The report explores business and technological trends in the U.S. market; provides market share estimates, as well as specimen, test, sales forecasts, and instrument placements; compares features of major analyzers; profiles leading competitors and emerging market entrants; and suggests specific product and marketing opportunities facing reagent and instrument suppliers.

Rationale

During the next five years, continued advances in molecular diagnostics, monoclonal antibodies, lasers and IT, as well as growing understanding of immunologic forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide. New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays. The introduction of smaller and easy-to-operate laser systems will further expand applications of flow cytometry to routine clinical laboratories. Further advances in IT will reduce the cost of instrument manufacture, service warranty, and permit development of self-troubleshooting, autocalibration and other advanced features. Presently tedious analyses of chromosomal abnormalities, DNA content, and lymphocyte subsets will become more automated and routine.

U.S. Market Overview
  • Facilities performing hematology and flow cytometry testing.
  • Test volume and sales projections.
Strategic Recommendations
  • New product development opportunities with significant market appeal.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
Market Segmentation Analysis: Sales and market share estimates for leading suppliers of hematology and flow cytometry products by country.
  • Specimen, test and sales forecasts for over 40 procedures by individual test and market segment:
    • Hospitals
    • Commercial/Private Laboratories
    • Physician Offices/Group Practices
    Sales and Market Share Analysis: Sales and market shares of major instrument and reagent suppliers.

    Hematology Tests: CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual), Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils.

    Flow Cytometry Tests: Cell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/RNA Analysis, Cell Culturing.

    Current and Emerging Products
    • Analysis of current and emerging hematology and flow cytometry assays.
    • Reagent and instrument sales forecasts by market segment.
    • Instrument placements and installed base by manufacturer and model.
    • Sales and market shares of reagent and instrument suppliers.
    Instrumentation Review
    • The study reviews current instrumentation technologies, and compares features of leading hematology, flow cytometry, platelet aggregation and sedimentation rate analyzers.
    • The report features analyzers manufactured by Abbott, Beckman Coulter/Danaher, Becton Dickinson, Biocode Hycel, CellaVision, Diesse Ves Matic, Drew-Scientific, Horiba, Medica, Menarini, Nihon Kohden, Polymedco, Siemens and Sysmex.
    Technology Review
    • Assessment of current and emerging technologies and their potential market applications.
    • Comprehensive lists of companies developing or marketing new technologies and products by test.
    Competitive Assessments

    Extensive strategic profiles of major suppliers and emerging market entrants.

    The companies analyzed in the report include:
    • Abbott
    • Agilent Technologies
    • Beckman Coulter/Danaher
    • Becton Dickinson
    • Bio-Rad
    • CellaVision
    • Horiba
    • Iris/Danaher
    • Nihon Kohden
    • Ortho-Clinical Diagnostics
    • Roche
    • Siemens
    • Sysmex
    Contains 275 pages and 36 tables
    I. Introduction

    II. Worldwide Market and Technology Overview

    A. Major Routine and Special Hematology Tests
      1. Introduction
      2. CBC Analysis
        a. Hemoglobin Concentration
        b. Hematocrit Determination
        c. Red Blood Cell Count
        d. Red Cell Indices
          MCV
          RDW
          MCHC
          CHCM
          HDW
          MCH
        e. Red Cell Size Histograms
        f. Platelets
          Platelet Count
          Platelet Size/MPV
          PDW
          Automated Systems
        g. Reticulocytes
      3. White Blood Cell Analysis
        a. WBC Count
        b. Five-Partial Differential Major Suppliers
          Abbott
          Beckman Coulter/Danaher
          Siemens
          Sysmex
        c. Pattern Recognition Systems
          IRIS
        d. Comparison of Major Differential Analyzers
      4. Reticulocytes
      5. Platelet Function Tests
      6. Erythrocyte Sedimentation Rate/CRP
      7. Red Cell Analysis
      8. 2, 3 DPG
      9. Red Cell Deformability
      10. Neutrophil Function Tests
      11. Semen Analysis
      12. Bone Marrow Analysis
      13. Urinalysis
    B. Major Flow Cytometry Applications
      1. Cell Surface Markers
        a. Lymphocyte Subclassification CD4/CD8/CD34
          Instrumentation and Reagent Test Kits
            BD
            Beckman Coulter/Danaher
            T Cells Diagnostics
        b. Other Cell Markers
      2. DNA Content Analysis
      3. RNA Content Analysis
      4. Chemotherapy Monitoring
      5. Cell Cycle Analysis
      6. Chromosome Analysis
      7. Fetal Cell Analysis
      8. HLA Typing
      9. Microbiology
      10. Protein Content Analysis
      11. Multiparameter Analysis
      12. Other Applications
    C. Instrumentation Review
      1. Hematology Analyzers
        a. Overview
          Electrical Aperture-Impedance Analyzers
          Light Scatter Analyzers
        b. System Review
          Abbott
          Beckman Coulter/Danaher
          Biocode Hycel
          CellaVision
          Drew-Scientific
          Horiba
          Medica
          Menarini
          Nihon Kohden
          Siemens
          Sysmex
      2. Flow Cytometers
        a. Introduction
        b. System Overview
          Becton Dickinson
          Beckman Coulter/Danaher
      3. Platelet Aggregometers
      4. Sedimentation Rate Analyzers
        Diesse Ves Matic
        Polymedco
    D. Current Market Needs and Future Demand For Hematology Analyzers
    E. Reagents and Controls
    F. Current and Emerging Technologies
      1. Molecular Diagnostics (Amplification Methods, Sequencing, Microarrays/Biochips)
      2. Information Technologies
      3. Automation and Robotics
      4. Lasers
      5. Artificial Intelligence
      6. Monoclonal Antibodies
      7. Microdrop Technology

    III. U.S.A.

    A. Executive Summary
    B. Business Environment
    C. Market Structure
    D. Market Size, Growth and Major Suppliers’ Instrument Placements, Installed Base, Sales and Market Shares

    IV. Major Product Development Opportunities

    A. Instrumentation
    B. Reagent Kits and Test Systems/Panels
    C. Information Technology
    D. Auxiliary Products

    V. Design Criteria for Decentralized Testing Products

    VI. Alternative Market Penetration Strategies

    A. Internal Development
    B. Collaborative Arrangements
    C. University Contracts
    D. Distribution Strategies for the Decentralized Testing Markets
      1. Four Marketing Approaches
      2. Product Complexity Factor
      3. Customer Preference Factor
      4. Established Suppliers
      5. Emerging Suppliers
      6. Major Types of Distributors
      7. Market Segmentation Factor

    VII. Potential Market Entry Barriers and Risks

    A. Market Maturity
    B. Cost Containment
    C. Competition
    D. Technological Edge and Limitations
    E. Patent Protection
    F. Regulatory Constraints
    G. Decentralized Testing Market Challenges

    VIII. Competitive Assessments

    Abbott
    Agilent Technologies
    Beckman Coulter/Danaher
    Becton Dickinson
    Bio-Rad
    CellaVision
    Horiba
    Iris
    Nihon Kohden
    Ortho-Clinical Diagnostics
    Roche
    Siemens
    Sysmex

    IX. Appendix: Major Universities and Research Centers Developing Hematology/Flow Cytometry Technologies and Applications

    LIST OF TABLES

    Summary Table I:U.S., All Market Segments, Total Hematology and Flow Cytometry Specimen Volume Forecast
    Summary Table II:U.S., All Market Segments, Total Hematology and Flow Cytometry Test Volume Forecast
    Summary Table III:U.S., All Market Segments, Total Hematology and Flow Cytometry Market Forecast
    U.S., Laboratories Performing Hematology/Flow Cytometry Testing By Market Segment
    U.S., Hospital Laboratories Performing Hematology and Flow Cytometry Tests By Bed Size
    U.S., Commercial/Private Laboratories Performing Hematology/Flow Cytometry Tests By Annual Test Volume
    U.S., Physician Offices/Group Practices Performing Hematology/Flow Cytometry Tests By Annual Test Volume
    U.S., Total Routine Hematology Specimen Volume Forecast By Market Segment
    U.S., Total Flow Cytometry and Special Hematology Specimen Volume Forecast By Market Segment
    U.S., Hospital Laboratories, Hematology and Flow Cytometry Specimen Volume Forecast
    U.S., Physician Offices/Group Practices, Hematology and Flow Cytometry Specimen Volume Forecast
    U.S., Commercial/Private Laboratories, Hematology and Flow Cytometry Specimen Volume Forecast
    U.S., Total Routine Hematology Test Volume Forecast By Market Segment
    U.S., Total Flow Cytometry and Special Hematology Test Volume Forecast By Market Segment
    U.S., All Market Segments, Total Routine Hematology Test Volume Forecast
    U.S., Hospital Laboratories, Routine Hematology Test Volume Forecast
    U.S., Commercial/Private Laboratories, Routine Hematology Test Volume Forecast
    U.S., Physician Office Laboratories, Routine Hematology Test Volume Forecast
    U.S., All Market Segments, Flow Cytometry and Special Hematology Test Volume Forecast
    U.S., Hospital Laboratories, Flow Cytometry and Special Hematology Test Volume Forecast
    U.S., Commercial/Private Laboratories, Flow Cytometry and Special Hematology Test Volume Forecast
    U.S., Physician Office Laboratories, Flow Cytometry and Special Hematology Test Volume Forecast
    U.S., Major Hematology Analyzers, Estimated Placements and Installed Base
    U.S., Major Flow Cytometers, Estimated Placements and Installed Base
    U.S., Total Hematology Market By Market Segment Forecast
    U.S., Hematology Instrument Market By Markets Segment Forecast
    U.S., Hematology Consumable Market By Market Segment Forecast
    U.S., Total Flow Cytometry Market Forecast By Market Segment
    U.S., Flow Cytometry Consumable Market Forecast By Market Segment
    U.S., Flow Cytometry Instrument Market Forecast By Market Segment
    U.S., Total Hematology Market By Major Supplier
    U.S., Hematology Instrument Market By Major Supplier
    U.S., Hematology Consumable Market By Major Supplier
    U.S., Total Flow Cytometry Market By Major Supplier
    U.S., Total Flow Cytometry Consumable Market By Major Supplier
    U.S., Total Flow Cytometry Instrument Market By Major Supplier


    More Publications